Course Syllabus

Course syllabus

 

COMMUNICABLE DISEASE I” Infectious and parasitic pathology”

 

Facilitator’s information:

 

IGIKUNDIRO Christine, Bachelor’s degree in general nursing

²  General Staff Office, Kabgayi SNM

²  Email: igikundiro7@yahoo.fr

²  Phone number: 0788584562

Course’s information:

 

²  Module: III

²  Credit Hours: 3

²  Pre-Requisites: Hospital and Environment Hygiene, Procedures/Techniques, Parasitology, General pharmacology, Microbiology.  

²  Location of Classroom: 1st year classroom

²  Time Slot: 45Hours

²  Grading: 30marks

 

Course Description: The course of communicable disease applies critical thinking skills when analyzing situation emerging from health related problems and contribute to its solution/ Establish and maintain professional relationships and communication

 

Purpose of the Course: The purpose of this course is to help / allow the student be able to prevent and treat the infectious and parasitic disease

Course Goals/Objectives:

 

• General objective:

                              

ü  At the end of the course the  students will be able to take charge of a client/patient suffering of bacterial and parasitic diseases

• Specific objectives:

 

                         At the end of the course the student will be able to:

      Define the studies infectious and parasitic diseases/illness

      Identify these diseases etiology

      Describe these diseases signs

      Explain these diseases complications

      Quote the diagnosis means of these diseases

      Determine the behavior to take in the event of infectious and parasitic diseases

      Analyze the physical and complementary/supplementary examinations results that lead to the diagnosis

      Prescribe the treatment to any client/patient suffered of an infectious disease

      Establish a link between the signs of the disease and its evolution

 

Student Learning Outcomes:

 

At the end of the course, the  students will be able to:

 

•  Make decisions which are favorable to the resolution of a problem or

       taking charge of this one.

• Adopt an understanding attitude towards his client/ patient
• Have self control over fears of certain diseases contagions/ contamination

Teaching and Learning Strategies:

 

The teaching and learning process will employ a mixture of methods to make it interesting for the learner and the following will mainly be used:

 

ü  group discussion

ü  Case studies

ü  Lecture

ü  Narrative lectures

ü  Vsee

Learning materials:

v  Handouts

v  Computer-based materials

v  Flipchart/blackboard

v  Printed materials.

Assignment:

²  Students are expected to submit all assignments on time, and should come to each class prepared to present what they have completed from their assignments. Those who are late to submit their assignments will lose 5% per day, up to a total of 5 days, then after the student will receive a mark of zero.

 

N.B: Plagiarism is not acceptable in any academic work. Any evidence of plagiarism in any assignment might lead to annulling the assignment and disciplinary hearing. Plagiarism refers to using somebody else’ work and handing it in for marking and/ or for credit as your own without acknowledge the author through direct quotation, citation, or in a reference list

 

Methods of assessments:

Learning will be assessed through continuous/formative and summative assessment.

Evaluation criteria:

There will be a series of assessments for this course:

-       Formative assessment and summative assessment

-       Formative assessment will be given before each chapter and students will present their findings in the following class.

-       Summative assessment will be given at the end of the course.

 

 

Grading Criteria:

The exam for this course will be derived at the end of course. It will be worth a total of 60% of the student’s final grade. The exam will test students on all topics covered in class and on the information discussed in each assignment

Continuous Assessment test……......……………......…………………..40%

                           Assignments……………………………………………..20%

                           Individual test……………………………………………20%

Final Exam………………………………………………...………….…..60%

 

Total………………………………….……………………………...…….100%

                 

Attendance criteria:

 

²  Students are expected to attend all classes and to arrive to class on time each day. Those who are unable to do so, for medical reasons, should contact the teacher as soon as possible and seek to obtain class notes from their classmates for any time they have missed. Those for without reasons who are not attended 2/3 of the course will not be evaluated.

²  Students are required to turn all cell phones off during each class, as this is distracting to the teacher and to other students. 

²  Students are expected to actively participate in all classes. It is encouraged that all students provide opinions, ask questions, and stay actively involved in class discussions.

 

References:

 

 Atkinson W, Hamborsky J, McIntyre L, Wolfe S, 2009. "Poliomyelitis" (PDF). Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book) (11th ed.). Washington DC: Public Health Foundation. pp. 231–44.

Beaglehole, R. and Bonita, R.K.(2006). Basic epidemiology. Geneva: WHO

Brisson M, Gay N, Edmunds W, Andrews N, 2002. "Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox". Vaccine 20 (19–20): 2500–7.

Chamberlin SL, Narins B, 2005. The Gale Encyclopedia of Neurological Disorders. Detroit: Thomson Gale. pp. 1859–70. 

Cohen JI, 2004. Harrison's Principles of Internal Medicine (16th ed.). McGraw-Hill Profesional. pp. 1144.

 

Dr Harvcy. M (2010) black’s medical dictionary, 42^nd edition

Jefferson T, Del Mar C, Dooley L, et al.,2009. "Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review". BMJ 339: b3675. 

Kasper et al, 2005.Harrison’s Principles of Internal Medicine 16^th ed,

 Katz, Samuel L.; Gershon, Anne A.; Krugman, Saul; Hotez, Peter J., 2004. Krugman's infectious diseases of children. St. Louis: Mosby. pp. 81–97. 

Kawaoka Y (editor), 2006. Influenza Virology: Current Topics. Caister Academic Press. 

 Larson EL, Lin SX, Gomez-Pichardo C, Della-Latta P, 2004. "Effect of antibacterial home cleaning and handwashing products on infectious disease symptoms: a randomized, double-blind trial". Ann. Intern. Med. 140 (5): 321–9. 

Lippincott .W, Wilkins(2005) pediatric nursing incredibly easy,

Margaret, 2007. Essential of human diseases and conditions, retrieved oct. 2011 from http://evolve.elsevier.com

 McCusker, J. (2001). Epidemiology in community health. A self teaching manual for rural health workers.(rev.ed). Nairobi: English press (K) Ltd

MOH, (2007). Guide therapeutique standard , 1^ere Edition, page 105-153

Monahan, P. and Marck, S. (2003). Medical surgical nursing : health and illness perspectives , 7^th  Ed. Missouri.

Murray, L. and Ian, W. (2001). Hand book of clinical Medicine, 5^th Edition, Oxford University Press Inc., New York, Page 538-620

Nordberg, E. (2001). Communicable diseases. A manual for health workers in Sub-Saharan Africa , 3^rd Edition , African Medical and Research Foundation (AMREF), Nairobi, Kenya

Paryani SG, Arvin AM (1986). "Intrauterine infection with varicella-zoster virus after maternal varicella". N. Engl. J. Med. 314 (24): 1542–6.

Ryan KJ, Ray CG, 2004. "Enteroviruses".Sherris Medical Microbiology (4th ed.). McGraw Hill. pp. 535–7.

Thomas SL, Wheeler JG, Hall AJ, 2006. "Micronutrient intake and the risk of herpes zoster: a case-control study". Int J Epidemiol 35 (2): 307–14.

Trac plus, 2010. Guidelines  for the management of opportunistic infections in adults with HIV-AIDS in Rwanda, Kigali Rwanda , may 2010..

Trac plus, 2009. Guidelines for the provision of comprehensive care to persons infected by HIV in Rwanda ,Kigali Rwanda ,may 2009.

Trevelyan B, Smallman-Raynor M, Cliff A, 2005. "The Spatial Dynamics of Poliomyelitis in the United States: From Epidemic Emergence to Vaccine-Induced Retreat, 1910–1971". Ann Assoc Am Geogr 95 (2): 269–93.

Tyring SK,2007. "Management of herpes zoster and postherpetic neuralgia". J Am Acad Dermatol 57 (6 Suppl): S136–42.

Winther B, Arruda E, Witek TJ, et al., 2002. "Expression of ICAM-1 in nasal epithelium and levels of soluble ICAM-1 in nasal lavage fluid during human experimental rhinovirus infection". Arch. Otolaryngol. Head Neck Surg. 128 (2): 131–6

CONTENT TO BE DEVELOPED

 

CHAPTER I: GENERAL INFORMATION

I.1Definition of key terms

I.2 Importance of communicable disease in Africa

I.3 Factors necessary for the existence of a communicable disease

I.4 The host and infection

I.5 Phases of an infectious disease evolution

I.6 Carriers of infection

I.7 Epidemiology of the infectious and parasitic illnesses

I.8 Definition of some terminology

I.9 Principals of communicable disease control

I.10 Application of community control measures against communicable disease

I.11 Procedure for investigation, management and control of epidemics

I.12 Resistance to infectious disease (IMMUNITY)

I.13 Symptomatology of infection: INFECTIOUS SYNDROME

I.14 Inflammation

I.15 Classification of infectious and parasitic diseases

 

CHAPTER II.  BACTERIAL DISEASES

 

II.1 Typhoid fever

II.2 Tetanus

II.3 Meningitis

II.4 Tuberculosis

II.5 Leprosy

II.6 Bacillary dysentery

II.7 Cholera

II.8 Syphilis

II.9 Chancroid (Soft sore)

II.10 Gonorrhea

 

 

CHAPTER III. PARASITIC DISEASES

 

III.1 Malaria

III.2 Amoebiasis

III.3 Giardiasis

III.4 Ascariasis

III.5 Hookworm

III.6 Trichomoniasis

III.7 Bilharziosis (Schistosomiasis)

III.8 Trypanosomiasis

III.9   Tapeworm (Taeniasis)

III.10 Filariosis

III.11 Trichiuriasis

III.12 Pinworm

 

CHAPTER IV: VIRAL INFECTIONS

4.1.HIV/ AIDS

4.2. Influenza/coryza

4.3. Chicken pox and shingles

4.4Hemorrhagic fever

4.5Yellow fever

4.6. Herpes

4.7. Rabies

4.8. Poliomyelitis

4.9. Infectious mononucleosis/glandular

4.10. Infection with cytomegalovirus

 

CHAPTER V: FUNGIC INFECTIONS OR FUNGI

 

5.1 Candidosis

5.2 Ptyriasis versicolor

5.3 Dermatophyties

5.4 Cryptoccosis

5.5 Aspergiollosis